2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Leiomyoma
4
Papillomavirus Infections
3
Inflammation
2
Frailty
2
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Squamous Intraepithelial Lesions
1
Small Cell Lung Carcinoma
1
Radiodermatitis
1
Prostatic Neoplasms
1
Papilloma
1
Low-Grade Intraepithelial Neoplasia of Cervix
1
Liver Neoplasms
1
Liver Cirrhosis
1
Fibrosis
1
Esophageal Neoplasms
1
Deglutition Disorders
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Atypical Squamous Cells of the Cervix
1
Interventions
Low-Level Light Therapy
8
Standard of Care
5
Petrolatum
3
Norepinephrine
3
triethanolamine
2
sapropterin
2
Sodium Chloride
2
Radiotherapy
2
Curcumin
2
Biafine
2
eucerin
1
epigallocatechin gallate
1
dimethicone
1
cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion
1
calcipotriene
1
Zinc Oxide
1
Triamcinolone Acetonide
1
Thioctic Acid
1
Sodium Hypochlorite
1
Silver Sulfadiazine
1
Radiotherapy, Conformal
1
Practice Guidelines as Topic
1
Melatonin
1
Laser Therapy
1
Hydrogel, Polyethylene Glycol Dimethacrylate
1
Hydrocortisone
1
Gels
1
Dimethyl Sulfoxide
1
Centella asiatica extract
1
Catechin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Radiodermatitis
×
epigallocatechin gallate
×
Clear all
NCT07149506
2025-09-08
OCTOPUS-RD
Universidad de Guanajuato
Phase 3
Enrolling by invitation
162 enrolled